E Fund Management Co. Ltd. Takes $43,000 Position in The Clorox Company (NYSE:CLX)

E Fund Management Co. Ltd. purchased a new stake in shares of The Clorox Company (NYSE:CLX) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 221 shares of the company’s stock, valued at approximately $43,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CLX. Norges Bank purchased a new stake in shares of The Clorox during the 4th quarter valued at about $254,283,000. American International Group Inc. increased its holdings in The Clorox by 1,577.5% in the 4th quarter. American International Group Inc. now owns 768,550 shares of the company’s stock worth $155,186,000 after acquiring an additional 722,734 shares in the last quarter. Squarepoint Ops LLC increased its holdings in The Clorox by 494.5% in the 4th quarter. Squarepoint Ops LLC now owns 270,078 shares of the company’s stock worth $54,534,000 after acquiring an additional 224,647 shares in the last quarter. Dearborn Partners LLC increased its holdings in The Clorox by 1,145.3% in the 1st quarter. Dearborn Partners LLC now owns 189,629 shares of the company’s stock worth $36,576,000 after acquiring an additional 174,401 shares in the last quarter. Finally, Willis Investment Counsel purchased a new stake in The Clorox in the 4th quarter worth approximately $28,838,000. 78.10% of the stock is owned by hedge funds and other institutional investors.

Shares of CLX opened at $176.32 on Friday. The company has a market capitalization of $21.93 billion, a P/E ratio of 24.59, a PEG ratio of 3.36 and a beta of 0.20. The stock has a fifty day moving average of $184.43. The Clorox Company has a 52-week low of $175.25 and a 52-week high of $239.87. The company has a debt-to-equity ratio of 2.65, a quick ratio of 0.70 and a current ratio of 1.08.

The Clorox (NYSE:CLX) last released its earnings results on Thursday, April 29th. The company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.48 by $0.14. The Clorox had a return on equity of 104.74% and a net margin of 12.27%. The business had revenue of $1.78 billion for the quarter, compared to analyst estimates of $1.86 billion. During the same quarter last year, the firm posted $1.89 earnings per share. The business’s revenue was down .1% compared to the same quarter last year. On average, sell-side analysts anticipate that The Clorox Company will post 7.59 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 13th. Shareholders of record on Wednesday, July 28th will be paid a $1.16 dividend. This is a positive change from The Clorox’s previous quarterly dividend of $1.11. The ex-dividend date is Tuesday, July 27th. This represents a $4.64 dividend on an annualized basis and a yield of 2.63%. The Clorox’s dividend payout ratio (DPR) is presently 60.33%.

Several research analysts have weighed in on CLX shares. DA Davidson dropped their price target on The Clorox from $189.00 to $177.00 and set a “neutral” rating for the company in a research note on Monday, May 3rd. Morgan Stanley dropped their price target on The Clorox from $183.00 to $170.00 and set an “underweight” rating for the company in a research note on Monday, May 3rd. Atlantic Securities upgraded The Clorox from a “neutral” rating to an “overweight” rating and set a $233.00 price target for the company in a research note on Friday, February 19th. Royal Bank of Canada restated a “neutral” rating on shares of The Clorox in a research note on Wednesday, May 5th. Finally, Argus dropped their price target on The Clorox from $230.00 to $206.00 and set a “buy” rating for the company in a research note on Friday, May 21st. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $207.94.

The Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.

Recommended Story: Why are trading ranges significant?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.